{
  "directed": true,
  "graph": {
    "annotation_list": {},
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "Disease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno",
      "Gender": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno",
      "Subgraph": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno",
      "TextLocation": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"
    },
    "document_metadata": {
      "authors": "Esther Wollert",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright © 2019 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "Axonal Transport, Tau Protein, and Neurodegeneration in Alzheimer’s Disease",
      "version": "1.0.0"
    },
    "namespace_pattern": {
      "DBSNP": "rs[0-9]+",
      "PUBCHEM": "^\\d+$",
      "TAXONOMY": "^\\d+$",
      "UNIPROT": "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\\.\\d+)?$"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns",
      "CONSO": "https://raw.githubusercontent.com/pharmacome/conso/501ceccdc9a27d97edbdc48a89ebe8e1dd3626e9/export/conso-names.belns",
      "DRUGBANK": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/drugbank-names.belns",
      "ECCODE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns",
      "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/a5b84013a08880975ca84f40999e4404b14a97e2/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns",
      "HGNCGENEFAMILY": "https://raw.githubusercontent.com/pharmacome/terminology/73688d6dc24e309fca59a1340dc9ee971e9f3baa/external/hgnc.genefamily-names.belns",
      "HP": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/hp-names.belns",
      "INTERPRO": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/interpro-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/01c9daa61012b37dd0a1bc962521ba51a15b38f1/external/mesh-names.belns",
      "MGI": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/mgi-names.belns",
      "MIRBASE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/mirbase-names.belns",
      "NCBIGENE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/entrez.belns",
      "PFAM": "https://raw.githubusercontent.com/pharmacome/terminology/8ccfed235e418e4c8aa576f9a5ef0f838e794c7f/external/pfam-names.belns",
      "RGD": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/rgd-names.belns"
    },
    "path": "pp2a/terwel2002.bel",
    "pybel_version": "0.14.10"
  },
  "links": [
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": "Tau protein is a typical microtubule-associated protein (MAP) and thus is directly implicated in maintaining the integrity and stability of the micro- tubules and involved in axonal transport. On the other hand, recent findings propose a direct role for APP in axonal transport, as APP can link to kinesins moving along the microtubules (Kamal et al., 2001).",
      "key": "8b88f15f1802551f834896879cd2bfca",
      "line": 85,
      "relation": "increases",
      "source": 31,
      "target": 8
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": "Tau protein is a typical microtubule-associated protein (MAP) and thus is directly implicated in maintaining the integrity and stability of the micro- tubules and involved in axonal transport. On the other hand, recent findings propose a direct role for APP in axonal transport, as APP can link to kinesins moving along the microtubules (Kamal et al., 2001).",
      "key": "e667ae4d53b610d9ced96d98c5a818de",
      "line": 86,
      "relation": "association",
      "source": 31,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": "The microtubule-binding properties of tau protein are believed to be important for a number of processes, e.g., the formation and maintenance of axons and for fast axonal transport (FAT).",
      "key": "0e5d77894dc3926f627a8667fccf8059",
      "line": 106,
      "relation": "increases",
      "source": 31,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": "An important function of tau protein involves the stabilization and spacing of microtubules, proba- bly by linking to a number of tubulin subunits, thereby preventing or slowing microtubule depoly- merization (Drubin and Kirschner, 1986). ",
      "key": "7740b07d1a3bf6c4766ffecbfd3635c5",
      "line": 97,
      "relation": "decreases",
      "source": 31,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": "The microtubule-binding properties of tau protein are believed to be important for a number of processes, e.g., the formation and maintenance of axons and for fast axonal transport (FAT).",
      "key": "36283599ca1cbf7ecdfa96aaadd1bcdf",
      "line": 105,
      "relation": "increases",
      "source": 31,
      "target": 6
    },
    {
      "key": "064f60bbd4e86ec0d71e89e733af2e71",
      "relation": "hasVariant",
      "source": 31,
      "target": 33
    },
    {
      "key": "b5ef526ab5a17da51fd96bb875e02aac",
      "relation": "hasVariant",
      "source": 31,
      "target": 32
    },
    {
      "key": "27e9bee72dd577c70598500f0d691556",
      "relation": "partOf",
      "source": 31,
      "target": 12
    },
    {
      "key": "68a0a25cd42693f2ce524188531fafa9",
      "relation": "hasVariant",
      "source": 31,
      "target": 34
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": "Tau protein is a typical microtubule-associated protein (MAP) and thus is directly implicated in maintaining the integrity and stability of the micro- tubules and involved in axonal transport. On the other hand, recent findings propose a direct role for APP in axonal transport, as APP can link to kinesins moving along the microtubules (Kamal et al., 2001).",
      "key": "7d6ee37555eb2adbf9cfd91bae538878",
      "line": 86,
      "relation": "association",
      "source": 7,
      "target": 31
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": "Tau protein is a typical microtubule-associated protein (MAP) and thus is directly implicated in maintaining the integrity and stability of the micro- tubules and involved in axonal transport. On the other hand, recent findings propose a direct role for APP in axonal transport, as APP can link to kinesins moving along the microtubules (Kamal et al., 2001).",
      "key": "6e28fb2b114020f212f061c7c8c1b4c1",
      "line": 87,
      "relation": "association",
      "source": 7,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": "The following proposition has been recently reit- erated that axonal transport in AD could become disrupted by increased neuronal concentrations of tau protein",
      "key": "1d5c74f01d8118610f2ab579e69eee82",
      "line": 208,
      "relation": "negativeCorrelation",
      "source": 7,
      "target": 38
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": "The amount of Aβ produced could be altered by delayed axonal transport, as well as the precise species of metabolites of APPproduced— e.g., Aβ40 or 42, monomeric Aβ, or Aβ-oligomers or Aβ-derived diffusible ligands (ADDLs) (Lambert et al., 1998; Walsh et al., 2000).",
      "key": "451137ce2ca97824cb6310bcdb6cd11e",
      "line": 218,
      "relation": "association",
      "source": 7,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": "Although much further work is needed, these additional data demonstrate that GSK-3β is intimately involved in the architecture of axons and other neuronal processes, providing indirect support for its role in tau-mediated con- trol of axonal transport.",
      "key": "8a39eb847bf1d6c038a2fcd573115e54",
      "line": 266,
      "relation": "association",
      "source": 7,
      "target": 28
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": "Tau protein is a typical microtubule-associated protein (MAP) and thus is directly implicated in maintaining the integrity and stability of the micro- tubules and involved in axonal transport. On the other hand, recent findings propose a direct role for APP in axonal transport, as APP can link to kinesins moving along the microtubules (Kamal et al., 2001).",
      "key": "24094aa8d37993db24dee2e411983d9c",
      "line": 87,
      "relation": "association",
      "source": 23,
      "target": 7
    },
    {
      "key": "53e2f577226669c77e3d4f19315f928f",
      "relation": "partOf",
      "source": 23,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": "However, it is believed that the secreted form of APP plays important roles in neuronal plasticity and survival (Mattson, 1997).",
      "key": "2058ece054f469f5458c6a1d1f235eba",
      "line": 273,
      "relation": "association",
      "source": 23,
      "subject": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "target": 11
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": "However, it is believed that the secreted form of APP plays important roles in neuronal plasticity and survival (Mattson, 1997).",
      "key": "567c5b36eaae6e663fe3e865ceecaa30",
      "line": 274,
      "relation": "association",
      "source": 23,
      "subject": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "target": 10
    },
    {
      "key": "d6d89222a895fa8f09035b376e6accaa",
      "relation": "partOf",
      "source": 23,
      "target": 13
    },
    {
      "key": "a5807e5872edf787e376bd26e00ea574",
      "relation": "partOf",
      "source": 36,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": " Among the specific “proline-dependent” kinases that can phosphorylate protein tau at dif- ferent sites in vitro, special attention is dedicated to glycogen-synthase kinase-3β (GSK-3β) (Michel et al., 1998), mitogen-activated protein kinase (MAPK) (Drewes et al., 1992), stress-activated protein kinases (SAPKs) (Goedert et al., 1997) and cyclin-dependent kinases (CDKs) including cdc2 and cdk5 (Baumann et al., 1993; Patrick et al., 1999).",
      "key": "936ba38bc5f5cc044f01f532c82e3b24",
      "line": 120,
      "relation": "increases",
      "source": 28,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true,
          "Spinal Cord": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": "Neuronally overexpressed GSK-3β was demonstrated to hyperphosphorylate tau protein in vivo in the brain and spinal cord of double- transgenic mice (Spittaels et al., 2000) thereby reducing the amount of protein tau associated with microtubules by 50% (Spittaels et al., 2000).",
      "key": "36fdfed1bfcd3c7003dec5cd7359b797",
      "line": 230,
      "relation": "increases",
      "source": 28,
      "target": 32
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true,
          "Spinal Cord": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": "Neuronally overexpressed GSK-3β was demonstrated to hyperphosphorylate tau protein in vivo in the brain and spinal cord of double- transgenic mice (Spittaels et al., 2000) thereby reducing the amount of protein tau associated with microtubules by 50% (Spittaels et al., 2000).",
      "key": "50ee30e38131ab7b16feef028c765ce4",
      "line": 231,
      "relation": "decreases",
      "source": 28,
      "target": 12
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true,
          "Spinal Cord": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": " More- over, the unbound tau protein was hyperphospho- rylated and especially at the AD-2 epitope, e.g., an epitope shown to contain serine 396 and serine 404.",
      "key": "d270b2176849c81c2d4c9a373d03123a",
      "line": 243,
      "relation": "increases",
      "source": 28,
      "target": 34
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": "Surprisingly, the axonopathy was rescued in the tau x GSK-3β double-transgenic mice, together with a near-total normalization of the functional disabilities.",
      "key": "5061987491b54a1f07fc028c29c8c307",
      "line": 255,
      "relation": "increases",
      "source": 28,
      "target": 3
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": "Although much further work is needed, these additional data demonstrate that GSK-3β is intimately involved in the architecture of axons and other neuronal processes, providing indirect support for its role in tau-mediated con- trol of axonal transport.",
      "key": "cfcb3b9ed5665f2684dedc38f4091df6",
      "line": 266,
      "relation": "association",
      "source": 28,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": " Among the specific “proline-dependent” kinases that can phosphorylate protein tau at dif- ferent sites in vitro, special attention is dedicated to glycogen-synthase kinase-3β (GSK-3β) (Michel et al., 1998), mitogen-activated protein kinase (MAPK) (Drewes et al., 1992), stress-activated protein kinases (SAPKs) (Goedert et al., 1997) and cyclin-dependent kinases (CDKs) including cdc2 and cdk5 (Baumann et al., 1993; Patrick et al., 1999).",
      "key": "dd0b529119d4973f85f8d47f9870b44c",
      "line": 121,
      "relation": "increases",
      "source": 18,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": " Among the specific “proline-dependent” kinases that can phosphorylate protein tau at dif- ferent sites in vitro, special attention is dedicated to glycogen-synthase kinase-3β (GSK-3β) (Michel et al., 1998), mitogen-activated protein kinase (MAPK) (Drewes et al., 1992), stress-activated protein kinases (SAPKs) (Goedert et al., 1997) and cyclin-dependent kinases (CDKs) including cdc2 and cdk5 (Baumann et al., 1993; Patrick et al., 1999).",
      "key": "4e09873f3f68205bec8fdd7941c0ed83",
      "line": 122,
      "relation": "increases",
      "source": 30,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": " Among the specific “proline-dependent” kinases that can phosphorylate protein tau at dif- ferent sites in vitro, special attention is dedicated to glycogen-synthase kinase-3β (GSK-3β) (Michel et al., 1998), mitogen-activated protein kinase (MAPK) (Drewes et al., 1992), stress-activated protein kinases (SAPKs) (Goedert et al., 1997) and cyclin-dependent kinases (CDKs) including cdc2 and cdk5 (Baumann et al., 1993; Patrick et al., 1999).",
      "key": "178e290a983604ac2a6e760c87abcdc9",
      "line": 123,
      "relation": "increases",
      "source": 26,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": " Among the specific “proline-dependent” kinases that can phosphorylate protein tau at dif- ferent sites in vitro, special attention is dedicated to glycogen-synthase kinase-3β (GSK-3β) (Michel et al., 1998), mitogen-activated protein kinase (MAPK) (Drewes et al., 1992), stress-activated protein kinases (SAPKs) (Goedert et al., 1997) and cyclin-dependent kinases (CDKs) including cdc2 and cdk5 (Baumann et al., 1993; Patrick et al., 1999).",
      "key": "3928acac365daaa4f2228142b3ad31b1",
      "line": 124,
      "relation": "increases",
      "source": 27,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": "Other serine and threonine residues, not followed by proline, are phosphorylated by other protein kinases, including microtubule-affinity-regulating kinase (MARK) (Drewes et al., 1993), calcium/ calmodulin kinase II (CAMKII), cAMP-dependent kinase (PKA) (Johnson et al., 1992), and casein kinase II (Greenwood et al., 1994).",
      "key": "0614a81406b621b8d8f53a90c37389d1",
      "line": 135,
      "relation": "increases",
      "source": 35,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": "Other serine and threonine residues, not followed by proline, are phosphorylated by other protein kinases, including microtubule-affinity-regulating kinase (MARK) (Drewes et al., 1993), calcium/ calmodulin kinase II (CAMKII), cAMP-dependent kinase (PKA) (Johnson et al., 1992), and casein kinase II (Greenwood et al., 1994).",
      "key": "128cb54bc1bfe17f3a3b88745f6b735a",
      "line": 136,
      "relation": "increases",
      "source": 25,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": "Other serine and threonine residues, not followed by proline, are phosphorylated by other protein kinases, including microtubule-affinity-regulating kinase (MARK) (Drewes et al., 1993), calcium/ calmodulin kinase II (CAMKII), cAMP-dependent kinase (PKA) (Johnson et al., 1992), and casein kinase II (Greenwood et al., 1994).",
      "key": "63f33d7944cafb250dbbc9b549ef7fcd",
      "line": 137,
      "relation": "increases",
      "source": 19,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": "Other serine and threonine residues, not followed by proline, are phosphorylated by other protein kinases, including microtubule-affinity-regulating kinase (MARK) (Drewes et al., 1993), calcium/ calmodulin kinase II (CAMKII), cAMP-dependent kinase (PKA) (Johnson et al., 1992), and casein kinase II (Greenwood et al., 1994).",
      "key": "5d321852943b6b6208bf54380bc73487",
      "line": 138,
      "relation": "increases",
      "source": 17,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": " Tau protein is rapidly dephosphorylated by endogenous phosphatases such as protein phosphatases 1, 2A, and 2B (cal- cineurin) that are all present in the brain, and effec- tively dephosphorylate tau protein in vitro. ",
      "key": "5185a805dfb95f0fd268d8764a3f3971",
      "line": 148,
      "relation": "decreases",
      "source": 20,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": " Tau protein is rapidly dephosphorylated by endogenous phosphatases such as protein phosphatases 1, 2A, and 2B (cal- cineurin) that are all present in the brain, and effec- tively dephosphorylate tau protein in vitro. ",
      "key": "a85b6029e525123383c56325979f530a",
      "line": 149,
      "relation": "decreases",
      "source": 21,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": " Tau protein is rapidly dephosphorylated by endogenous phosphatases such as protein phosphatases 1, 2A, and 2B (cal- cineurin) that are all present in the brain, and effec- tively dephosphorylate tau protein in vitro. ",
      "key": "105376c4ca3dd7d8b4649b0c2a4a82ab",
      "line": 150,
      "relation": "decreases",
      "source": 22,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": " TSubsequently, Wallerian degeneration and severe muscle wasting and motoric problems demon- strated the extensive neurodegeneration caused by the overexpression of human tau protein in a gene- dosage fashion.",
      "key": "51676a58788f92d746acfc79404c4838",
      "line": 162,
      "relation": "increases",
      "source": 16,
      "target": 42
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": " TSubsequently, Wallerian degeneration and severe muscle wasting and motoric problems demon- strated the extensive neurodegeneration caused by the overexpression of human tau protein in a gene- dosage fashion.",
      "key": "a948cae4c05febae87764bb59524fa59",
      "line": 163,
      "relation": "increases",
      "source": 16,
      "target": 41
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": " TSubsequently, Wallerian degeneration and severe muscle wasting and motoric problems demon- strated the extensive neurodegeneration caused by the overexpression of human tau protein in a gene- dosage fashion.",
      "key": "477eca1d69761e1a25710787cee42fa7",
      "line": 164,
      "relation": "increases",
      "source": 16,
      "target": 37
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": "Evidently, this argues for critical levels of protein tau-4R in the pathology of FTD and by exten- sion, in AD.",
      "key": "0036481d4d0252fba3ce509428ed9b92",
      "line": 199,
      "relation": "positiveCorrelation",
      "source": 16,
      "target": 40
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": "Evidently, this argues for critical levels of protein tau-4R in the pathology of FTD and by exten- sion, in AD.",
      "key": "75a694ee568b5c2614256634c2e77525",
      "line": 200,
      "relation": "positiveCorrelation",
      "source": 16,
      "target": 38
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": ". In ALS, accumulation of NFs is a prominent feature (Rouleau et al., 1996), and it has been demonstrated that NFs contribute heavily to the axonopathy of tau transgenic mice (Ishihara et al., 2001a).",
      "key": "af25231ddc3fbdca990c1b514f0acfcd",
      "line": 174,
      "relation": "positiveCorrelation",
      "source": 39,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": ". In ALS, accumulation of NFs is a prominent feature (Rouleau et al., 1996), and it has been demonstrated that NFs contribute heavily to the axonopathy of tau transgenic mice (Ishihara et al., 2001a).",
      "key": "9c5a6abd05a0b44da96400a7036cd6a2",
      "line": 174,
      "relation": "positiveCorrelation",
      "source": 2,
      "target": 39
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": ". In ALS, accumulation of NFs is a prominent feature (Rouleau et al., 1996), and it has been demonstrated that NFs contribute heavily to the axonopathy of tau transgenic mice (Ishihara et al., 2001a).",
      "key": "25754e50ad91c30e23f8ebc7db05b274",
      "line": 176,
      "relation": "negativeCorrelation",
      "source": 2,
      "target": 3
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": ". In ALS, accumulation of NFs is a prominent feature (Rouleau et al., 1996), and it has been demonstrated that NFs contribute heavily to the axonopathy of tau transgenic mice (Ishihara et al., 2001a).",
      "key": "303efaa9f0e93743afeb53bcdff6070c",
      "line": 176,
      "relation": "negativeCorrelation",
      "source": 3,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": "For the sake of completeness, we also refer to tau- 3R transgenic mice that developed another type of pathology in the hippocampus, e.g., straight fila- ments formed in aged mice older than 18 mo (Ishi- hara, 2001b), which was proposed to be relevant for AD, given the age-dependence.",
      "key": "0f8bb5d96fd905af5d1744deb2a4e611",
      "line": 189,
      "relation": "increases",
      "source": 15,
      "target": 1
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": "For the sake of completeness, we also refer to tau- 3R transgenic mice that developed another type of pathology in the hippocampus, e.g., straight fila- ments formed in aged mice older than 18 mo (Ishi- hara, 2001b), which was proposed to be relevant for AD, given the age-dependence.",
      "key": "03d9a69982abd96b99e783861140130a",
      "line": 190,
      "relation": "association",
      "source": 1,
      "target": 38
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": "For the sake of completeness, we also refer to tau- 3R transgenic mice that developed another type of pathology in the hippocampus, e.g., straight fila- ments formed in aged mice older than 18 mo (Ishi- hara, 2001b), which was proposed to be relevant for AD, given the age-dependence.",
      "key": "05ef1cbc6b9d601d80b6d601298de474",
      "line": 190,
      "relation": "association",
      "source": 38,
      "target": 1
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": "Evidently, this argues for critical levels of protein tau-4R in the pathology of FTD and by exten- sion, in AD.",
      "key": "8feedf3232999e8db47ee7e92eaa415c",
      "line": 200,
      "relation": "positiveCorrelation",
      "source": 38,
      "target": 16
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": "The following proposition has been recently reit- erated that axonal transport in AD could become disrupted by increased neuronal concentrations of tau protein",
      "key": "28d9377eae1c27d933d14cfcab1b44f7",
      "line": 208,
      "relation": "negativeCorrelation",
      "source": 38,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true,
          "Spinal Cord": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": " More- over, the unbound tau protein was hyperphospho- rylated and especially at the AD-2 epitope, e.g., an epitope shown to contain serine 396 and serine 404.",
      "key": "48073fea67b081c311243e9d074c7332",
      "line": 244,
      "relation": "association",
      "source": 38,
      "target": 34
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": "Evidently, this argues for critical levels of protein tau-4R in the pathology of FTD and by exten- sion, in AD.",
      "key": "13315801367c80ca4a968ae96344ad93",
      "line": 199,
      "relation": "positiveCorrelation",
      "source": 40,
      "target": 16
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": "The amount of Aβ produced could be altered by delayed axonal transport, as well as the precise species of metabolites of APPproduced— e.g., Aβ40 or 42, monomeric Aβ, or Aβ-oligomers or Aβ-derived diffusible ligands (ADDLs) (Lambert et al., 1998; Walsh et al., 2000).",
      "key": "73e4d7f955ac73d21188362ab80a7cf2",
      "line": 218,
      "relation": "association",
      "source": 0,
      "target": 7
    },
    {
      "key": "e558b795ef63fded554616c630017346",
      "relation": "partOf",
      "source": 4,
      "target": 12
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true,
          "Spinal Cord": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": " More- over, the unbound tau protein was hyperphospho- rylated and especially at the AD-2 epitope, e.g., an epitope shown to contain serine 396 and serine 404.",
      "key": "c111d3369cf788b5f33ba848d4cac796",
      "line": 244,
      "relation": "association",
      "source": 34,
      "target": 38
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": "However, it is believed that the secreted form of APP plays important roles in neuronal plasticity and survival (Mattson, 1997).",
      "key": "78198a47705b556641d4b7f8c6fd9f30",
      "line": 273,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "association",
      "source": 11,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": "However, it is believed that the secreted form of APP plays important roles in neuronal plasticity and survival (Mattson, 1997).",
      "key": "acb938c63b103e8ee5543619f7a8f5b5",
      "line": 274,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "association",
      "source": 10,
      "target": 23
    },
    {
      "key": "86c8dfefaf07cbf21b1ee19e5a4587f4",
      "relation": "partOf",
      "source": 29,
      "target": 13
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": "Most recently, this role became even more puz- zling, since APP was implemented as a kinesin-1 receptor (Kamal et al., 2000; 2001). APP apparently binds to the light chain of kinesin-1, which itself is responsible for anterograde axonal transport and consists of two light chains (KLC) associated with two heavy chains (KIF5B).",
      "key": "881e484f1224a58fd4e864d2fb3c921f",
      "line": 286,
      "relation": "increases",
      "source": 29,
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "db": "PubMed",
        "db_id": "12428809",
        "db_name": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "first": "Terwel D",
        "journal": "Neuromolecular medicine",
        "last": "Van Leuven F",
        "pages": "151-65",
        "volume": "2"
      },
      "evidence": "Deletion  of  the C-terminus of APP695 or APPL, including the kinesin-binding region, disrupted axonal transport of APP695 and APPL.",
      "key": "ef51eda00d4b044f511544ed73801637",
      "line": 294,
      "relation": "increases",
      "source": 24,
      "target": 5
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"amyloid-beta\")",
      "concept": {
        "name": "amyloid-beta",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "e9557ea6ec74113b73fe23f4bd76b524"
    },
    {
      "bel": "a(CONSO:\"straight filaments\")",
      "concept": {
        "name": "straight filaments",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "d5002fa1072df1ac59c5d881696b20bf"
    },
    {
      "bel": "a(MESH:\"Intermediate Filaments\")",
      "concept": {
        "name": "Intermediate Filaments",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "1b61c7faab09fc5cd1e62f558df53e2b"
    },
    {
      "bel": "a(MESH:Axons)",
      "concept": {
        "name": "Axons",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "438b15a6e68338bcf5615b067cf5d271"
    },
    {
      "bel": "a(MESH:Microtubules)",
      "concept": {
        "name": "Microtubules",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "86177bbdcc4ebe2f7b5ae56407358336"
    },
    {
      "bel": "bp(GO:\"anterograde axonal transport\")",
      "concept": {
        "name": "anterograde axonal transport",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "b766d460857e8e5379a1a487bea86929"
    },
    {
      "bel": "bp(GO:\"axon development\")",
      "concept": {
        "name": "axon development",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "cb264ad706c25d23fedde395dca1ca2f"
    },
    {
      "bel": "bp(GO:\"axonal transport\")",
      "concept": {
        "name": "axonal transport",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "c9d614fb05004498d4069f216f0458c8"
    },
    {
      "bel": "bp(GO:\"microtubule cytoskeleton organization\")",
      "concept": {
        "name": "microtubule cytoskeleton organization",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "cf1cff92aea7c9493e7b7d7d3df912d6"
    },
    {
      "bel": "bp(GO:\"microtubule depolymerization\")",
      "concept": {
        "name": "microtubule depolymerization",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "5acebe6e270d24f491273fca08528134"
    },
    {
      "bel": "bp(GO:\"negative regulation of neuron apoptotic process\")",
      "concept": {
        "name": "negative regulation of neuron apoptotic process",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "63cc2b017ab5931df6030810566e625a"
    },
    {
      "bel": "bp(GO:\"regulation of neuronal synaptic plasticity\")",
      "concept": {
        "name": "regulation of neuronal synaptic plasticity",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "c547001e8cd63956c88a4ee9fc4d68c6"
    },
    {
      "bel": "complex(a(MESH:Microtubules), p(HGNC:MAPT))",
      "function": "Complex",
      "id": "78f0e9133ea9c8a592988e0cbb6b0f88",
      "members": [
        {
          "bel": "a(MESH:Microtubules)",
          "concept": {
            "name": "Microtubules",
            "namespace": "MESH"
          },
          "function": "Abundance",
          "id": "86177bbdcc4ebe2f7b5ae56407358336"
        },
        {
          "bel": "p(HGNC:MAPT)",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7d1009217050e75d549c8c5aa83309a8"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:APP), p(HGNC:KLC1))",
      "function": "Complex",
      "id": "d52b5fc2637f8a49e5445fa4413b91ad",
      "members": [
        {
          "bel": "p(HGNC:APP)",
          "concept": {
            "name": "APP",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "d43ae551265c6b6a27038d0b036848cf"
        },
        {
          "bel": "p(HGNC:KLC1)",
          "concept": {
            "name": "KLC1",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "e9214aed9abf09228825bd71f923b54a"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:APP), p(HGNCGENEFAMILY:Kinesins))",
      "function": "Complex",
      "id": "8612fbe4f35e5c1bb89b36a7aba7171e",
      "members": [
        {
          "bel": "p(HGNC:APP)",
          "concept": {
            "name": "APP",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "d43ae551265c6b6a27038d0b036848cf"
        },
        {
          "bel": "p(HGNCGENEFAMILY:Kinesins)",
          "concept": {
            "name": "Kinesins",
            "namespace": "HGNCGENEFAMILY"
          },
          "function": "Protein",
          "id": "1c796e74db1fc34f3681f8074adb7767"
        }
      ]
    },
    {
      "bel": "p(CONSO:\"3R tau\")",
      "concept": {
        "name": "3R tau",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "246e602cb53558e945b03407c219c5e1"
    },
    {
      "bel": "p(CONSO:\"4R tau\")",
      "concept": {
        "name": "4R tau",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "c5fd156b7c1a309ed11b8dca3e247657"
    },
    {
      "bel": "p(FPLX:CK2)",
      "concept": {
        "name": "CK2",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "3ee4353c7f9805a74262f5bb5d2ea661"
    },
    {
      "bel": "p(FPLX:ERK)",
      "concept": {
        "name": "ERK",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "0dc4dd8e21abefb97f64a360af4aeb2b"
    },
    {
      "bel": "p(FPLX:PKA)",
      "concept": {
        "name": "PKA",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "7f28e2fd1e77e23e3fafb2c1c0969bc3"
    },
    {
      "bel": "p(FPLX:PPP1)",
      "concept": {
        "name": "PPP1",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "49153e9001a6187da8b433fcbc3026b0"
    },
    {
      "bel": "p(FPLX:PPP2)",
      "concept": {
        "name": "PPP2",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "366ec44be4bbd8d4b72b6829c348c1f8"
    },
    {
      "bel": "p(FPLX:PPP3)",
      "concept": {
        "name": "PPP3",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "93611b6683e2f2f52d1af23c00addcfd"
    },
    {
      "bel": "p(HGNC:APP)",
      "concept": {
        "name": "APP",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "d43ae551265c6b6a27038d0b036848cf"
    },
    {
      "bel": "p(HGNC:APPL)",
      "concept": {
        "name": "APPL",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "bef7a87e97db509fb3dc96510058a351"
    },
    {
      "bel": "p(HGNC:CAMK2B)",
      "concept": {
        "name": "CAMK2B",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "10db42e21c3fd0e3220e1e83fff20929"
    },
    {
      "bel": "p(HGNC:CDK2)",
      "concept": {
        "name": "CDK2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "10f419c217b25dc1a0363b7341b8e0b8"
    },
    {
      "bel": "p(HGNC:CDK5)",
      "concept": {
        "name": "CDK5",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "cb1e1b28f1d3fe30db837d601f26fe1b"
    },
    {
      "bel": "p(HGNC:GSK3B)",
      "concept": {
        "name": "GSK3B",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "8eaf29c9e491ff4e49619e77de92467c"
    },
    {
      "bel": "p(HGNC:KLC1)",
      "concept": {
        "name": "KLC1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "e9214aed9abf09228825bd71f923b54a"
    },
    {
      "bel": "p(HGNC:MAPK9)",
      "concept": {
        "name": "MAPK9",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "b6a850a2ae2442a003af2f8196e5773c"
    },
    {
      "bel": "p(HGNC:MAPT)",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "7d1009217050e75d549c8c5aa83309a8"
    },
    {
      "bel": "p(HGNC:MAPT, pmod(CONSO:hyperphosphorylation))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "0d2d8072f03dcdf148e658067d37b9cb",
      "variants": [
        {
          "concept": {
            "name": "hyperphosphorylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "a8fb3a87d5a0672c07462bb17c8b0947",
      "variants": [
        {
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 396), pmod(Ph, Ser, 404))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "4a1943ea35dd0f11cf4c30b8869a878e",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 396
        },
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 404
        }
      ]
    },
    {
      "bel": "p(HGNC:MARK1)",
      "concept": {
        "name": "MARK1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "e0a6140f504302cb521a3ae061548ab5"
    },
    {
      "bel": "p(HGNCGENEFAMILY:Kinesins)",
      "concept": {
        "name": "Kinesins",
        "namespace": "HGNCGENEFAMILY"
      },
      "function": "Protein",
      "id": "1c796e74db1fc34f3681f8074adb7767"
    },
    {
      "bel": "path(HP:Neurodegeneration)",
      "concept": {
        "name": "Neurodegeneration",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "ff6883c524d877c644e0ba4e8f3323aa"
    },
    {
      "bel": "path(MESH:\"Alzheimer Disease\")",
      "concept": {
        "name": "Alzheimer Disease",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "2ae8307f5fd59056199369691367cc96"
    },
    {
      "bel": "path(MESH:\"Amyotrophic Lateral Sclerosis\")",
      "concept": {
        "name": "Amyotrophic Lateral Sclerosis",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "73a119af95b8953eff6c1a96ee76f056"
    },
    {
      "bel": "path(MESH:\"Frontotemporal Dementia\")",
      "concept": {
        "name": "Frontotemporal Dementia",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "876d8dfbadfb211122e2ba889d763c19"
    },
    {
      "bel": "path(MESH:\"Muscular Atrophy\")",
      "concept": {
        "name": "Muscular Atrophy",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "d1543843032139a0fc55c88610e87f9c"
    },
    {
      "bel": "path(MESH:\"Wallerian Degeneration\")",
      "concept": {
        "name": "Wallerian Degeneration",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "380f9d25f23839c3191109543af57b32"
    }
  ]
}